We reported earlier that the methylation of unmethylated reovirus mRNA (reo mRNAu) by the cellular methylating enzymes is impaired in extracts of uninfected, interferon-treated Ehrlich ascites tumor cells (S30INT). We find now that after the methylation of reo mRNAu has stopped in S301NT, the RNA can be reisolated and further methylated in an extract of control cells (S30C). Thus the impairment of methylation in S301NT cannot be due to cleavage or irreversible inactivation of reo mRNAu. Freshly added reo mRNAu can be methylated in S301NT in which the methylation of previously added reo mRNAu has stopped.
S301NT in which the methylation of previously added reo mRNAu has stopped.
This indicates that the impairment is not due to the depletion ofS-adenosylmethionine (the methyl donor), the accumulation of S-adenosylhomocysteine (an inhibitor of methylation), or the irreversible inactivation of the methylating enzymes. It may be due, however, to the unavailability of reo mRNAu for methylation. The extent of the impairment of reo mRNAu methylation in S301NT decreases with an increasing concentration of reo mRNAu but is not affected by added poly(U), ribosomal RNA, or encephalomyocarditis virus RNA (an mRNA that is probably not capped or methylated at its 5' end). The methylation of reo mRNAu is also impaired in an extract from cells that have not been treated with interferon but with the interferon inducer poly(I) -poly(C). The inhibitor is apparently a macromolecule that is inactivated during incubation. It decreases the methylation at the 7 position of the 5' terminal guanylate residue. In vitro, the rate of reo mRNA synthesis by reovirus cores in the presence of S301NT is the same as in the presence of S30C. However, the methylation of the de novo synthesized reo mRNA by the core-associated methylating enzyme(s) in vitro is inhibited by S301NT but not by S30c. The relevance of these phenomena to the inhibition of reovirus replication in interferon-treated cells remains to be established.
Interferons are glycoproteins formed in a large variety of animal cells upon viral infection. They are released, interact with other cells, and inhibit in these the multiplication of various viruses (9) . We have been studying the nature of the impairment of reovirus replication in interferon-treated mouse L929 fibroblasts (L cells) and Ehrlich ascites tumor (EAT) cells (11, 15, 21 ; see also references 12 and 29) . After penetration into the cells, the reovirions are converted into subviral particles by removal and cleavage oftheir outer coat proteins. Each reovirion (and each subviral particle) contains 10 different genomic double-stranded RNA segments. Subviral particles isolated I Present address: Department de Biologie Moleculaire, Universite Libre de Bruxelles, Brussels, Belgium. 2 Present address: Department of Biological Sciences, Purdue University, West Lafayette, IN 47907. from infected cells and also reovirus cores produced by partial digestion of reovirions by chymotrypsin exhibit a transcriptase activity. When incubated in the presence of the four common ribonucleoside triphosphates, both types of particles synthesize reo mRNA's. Each of these mRNA's is transcribed from a different segment of the viral genome. The 10 reo mRNA's fall into three size classes according to sedimentation velocity: large ( l, 12, 13), medium (mi1, M2, M3), and small (s1, s2, S3, S4) mRNA's (19) . Reovirus cores also contain an enzyme (GTP:mRNA guanylyltransferase or capping enzyme) which attaches a guanylate residue to the 5' end of each of the reo mRNA's. This process is called capping. Its products, the capped reo mRNA's, have a 5' terminal G(5')ppp(5')Gp sequence. Other enzymes associated with reovirus cores catalyze the transfer of methyl residues from S-adenosylmethionine (SAM) to the 7 position of the above-noted 5' terminal guanylate residue and to the 2'-Oposition of the adjacent guanylate residue. We will refer to this process as methylation. m7G(5')ppp(5')GmpCp .... is the 5' nucleotide sequence of the methylated capped reo mRNA's that are synthesized by the virion-associated enzymes (26) .
Enzymes capping the 5' termini of mRNA's and enzymes methylating the cap structure are also present in uninfected eukaryotic cells (14, 24) . Many eukaryotic cellular and viral mRNA's are capped and methylated (26) . The methylation (but not the capping) of mRNA in vitro by both cellular and viral core-associated enzymes can be blocked by S-adenosylhomocysteine (SAH). The use of this inhibitor allows the synthesis of capped but unmethylated reoviral mRNA's (reo mRNAu) by the core-associated reovirion transcriptase and capping enzymes in vitro (26) . Experiments involving the use of reo mRNAu and of methylated and capped reo mRNA's (reo mRNAM) revealed that the presence of the methyl group at the 7 position of the 5' terminal guanylate residue of reo mRNA's is essential for the efficient translation of the mRNA in cell-free protein-synthesizing systems from wheat germ or from mouse L cells. Without this residue the viral mRNA apparently does not forn initiation complexes with wheat germ ribosomes (3, 4) .
In the course of attempts to uncover the steps of reovirus replication which are impaired in interferon-treated cells, we compared the methylation of added reo mRNAu in extracts of uninfected control EAT cells (S30C) with that in extracts of uninfected, interferon-treated EAT cells (S3OINT) (25) . We found that the methylation of added reo mRNAu by the host enzymes in S30INT was impaired. The impairment was not a consequence of the cleavage of the products of methylation, and its extent decreased with an increasing concentration ofreo mRNAu in the reaction mixture (21, 25) . Further characteristics of these and of related phenomena are the topic ofthis communication. Some of these results have been reported (S. Shaila, B. Lebleu, G. C. Sen (28) .
(ii) Human interferon. A preparation of crude human interferon (specific activity, 104 units/mg of protein) was obtained by the superinduction of the foreskin fibroblast strain FS-4 and assayed according to Havell and Vilcek (16) . The units for human interferons are NIH human interferon reference standard units (*G-0230901-52).
Cells and viruses. EAT cells (27) were grown at 37°C in suspension culture in F-14 medium supplemented with 7% fetal calf serum or in monolayers in F-15 medium supplemented with 7% fetal calf serum. Reovirus type 3 (Dearing strain) was used. Encephalomyocarditis (EMC) virus was grown, and EMC RNA was prepared according to Aviv et al. (1) . Mengo virus was grown under the same conditions as EMC virus. EAT ribosomal RNA was prepared in the following way. Total cytoplasmic RNA was extracted, and RNA containing poly(A) was separated from the rest by passing through an oligo(dT) cellulose column (2) . RNA lacking poly(A) was sedimented through a sucrose gradient, and RNA sedimenting at 18 and 28S was pooled and recovered.
Treatment of cells with interferon and the interferon inducer poly()-poly(C) and preparation of cell extracts (S30). Growing suspension cultures of cells were diluted to a density of 4 x 105 cells/ml and treated with 60 units of interferon per ml for 18 h. Treatment with interferon at this concentration caused over 95% decrease in the yield of vesicular stomatitis virus in a single growth cycle. S30 from interferon-treated cells (S30,NT) and from untreated cells (S30) were prepared as described earlier for L cells (13) , except that the solution in which the cells were washed was supplemented with 12 mM glucose and dithiothreitol was not included in the buffer. Unless otherwise indicated, the S30s were not preincubated and not Sephadex treated (i.e., the last step of the preparation was centrifugation at 30,000 x g for 15 min as described in reference 13). The treatment of EAT cells with the interferon inducer poly(I) -poly(C) (10 A.g/ml) in monolayers and the preparation of S30 [S30OlY(I).PlY(C)] from such cells and corresponding cells not treated with the interferon inducer have been described (6 (25) .
Alkaline phosphatase treatment of reo mRNA. To remove the 5' terminal phosphate residues from the 5' terminal ppG .... structure, the reo mRNAu was incubated with alkaline phosphatase (0.3 mg/ ml) in 50 mM Tris-chloride (pH 8.0) at 37°C for 10 min. Alkaline phosphatase was removed by extraction with phenol, and the RNA was recovered by dialysis and precipitation with ethanol ( Table 1) .
Analysis of reo mRNA by centrifugation through sucrose gradients. Aqueous samples containing labeled reo mRNA were layered on 12.5-ml linear sucrose gradients (7 to 20%, wt/vol) in 100 mM NaCl, 10 mM Tris-chloride (pH 7.5), and 5 mM EDTA. The gradients were centrifuged in the SB283 rotor in an IEC B-60 centrifuge at 2°C and 39,000 rpm for 12 h. Fractions of approximately 0.4 ml were collected from the bottom and counted after addition of 10 ml of ACS scintillation fluid (Fig. 2) .
Determination 1 and 7) . Assays of core transcription and core methylation. Reovirus cores were prepared by chymotrypsin treatment of purified reovirions according to the method of Both et al. (5) , except that the transcription reaction was done at 37°C, no Macaloid was added, and GTP was added after the formation of cores ( Fig. 9 and 10 ).
RESULTS
Impairment of reo mRNAu methylation is not due to faster cleavage of reo mRNA in S30MNT than in S30C. The 5' terminal sequence of the molecules serving as substrates for methylation in our reo mRNAu preparation (caplabeled, alkaline phosphatase-treated reo mRNAu) was G(5')pp*p(5')G .... (Fig. 1) . The methylation assay was based on the conversion of acid-soluble labeled material (methyl-labeled SAM) to acid-insoluble labeled material (methyl-labeled reo mRNA). In the experiment shown in Fig. 2A Kinetics ofdegradation ofCAP-labeled reo mRNAu in S30c and S30INT: analysis on sucrose gradients. A 100-pg portion of CAP-labeled reo mRNAu per ml was incubated under methylation conditions for 1 These results indicate that the impairment of reo mRNA methylation in S30INT cannot be the consequence of the irreversible inactivation of reo mRNAu as a substrate for methylation.
Freshly added reo mRNAu can be methylated in an S30INl -containing reaction mixture in which the methylation of previously added reo mRNAu has stopped. To eliminate the possibility that the impairment of reo mRNAu methylation in S301NT might be a consequence of either the depletion of SAM or the accumulation of SAH, or the irreversible inactivation of the methylating enzyme(s), the following experiment was performed (Fig. 4) are unlikely to be capped, since ppG (or at least pG) termini are thought to be needed for capping (22) . In the experiment described in Table  1 These observations prompted us to test the effect of double-stranded RNA on the impairment of methylation in S30INT* In the experiment described in Table 2 a reo mRNAu preparation that had been freed, as far as possible, from contaminating double-stranded RNA by repeated precipitation with 2 M LiCl was used. We tested the effect of the addition of 5 ,g of double-stranded reovirus RNA per ml on the methylation of the above reo mRNAu preparation in S30c and in S301NT. The results in Table 2 indicate that the addition of double-stranded RNA had no effect on either the extent of methylation in S30C or its impainnent in S301NT under our experimental conditions.
Effect of the addition of various singlestranded RNAs on the impairment of reo mRNAu methylation in S30INT. We have reported earlier that the impairment of reo mRNAu methylation in S301NT decreases upon increasing the concentration of reo mRNAu in the reaction mixture (25) . The results in Fig. 5 indicate that the inhibition can also be overcome by the addition of increasing quantities of reo mRNAM. Seventy-five percent of the molecules in the reo mRNAM preparation have m7GpppGmp .... at their 5' termini, and 25% have ppGp . . . (4) . Whether only one of the two types of molecules or both can overcome the impairment remains to be established.
We also tested the effect on the impairment of methylation of the addition of poly(U), ribosomal RNA, and EMC RNA. None of these RNAs seemed to overcome the impairment of reo mRNAu methylation in S3OINT (Table 3) when tested at a concentration at which reo mRNAu or reo mRNAM does partially overcome the inhibition.
Impairment of methylation in S30s prepared from cells treated with homologous or heterologous interferons or with the interferon inducer poly(I) * poly(C). The experiments in Table 4 (20) does not impair the methylation activity in the cell extract (experiment 2). The infection of interferon-treated or untreated cells with Mengo virus has little or no effect on the impairment of methylation in the cell extract (experiment 3). Treatment ofcells with a heterologous interferon does not impair the methylation in the cell extract (experiment 4). Methylation is inhibited in an extract from cells that were treated with the interferon inducer poly(I) * poly(C) (9) instead of the partially purified mouse interferon preparation (experiment 5). Characteristics of the inhibitor. (i) Impaired methylation in Sephadex-treated S301NT. To test whether the inhibitor is a macromolecule or not, the small molecules were removed from S30c and S301NT by gel filtration through Sephadex G-25. The data in Table 5 show that the impairment is manifested in Sephadex-treated S30INT. The extent of the impairment is, however, less than in a non-Sephadex-treated extract.
(ii) Inactivation of the inhibitor during incubation. To test whether the decrease in the impairment in S301NT upon Sephadex treatment is due to a partial inactivation of the inhibitor during gel filtration or due to its partial removal, the following experiment was performed. We incubated portions of Sephadextreated S30c and S301NT at 37°C for various lengths of time (preincubation) before testing their capacity to methylate reo mRNAu. The data in Fig. 6 reveal that the extent of methyla- a The reo mRNAu concentration was 100 ,g/ml in all experiments, except in experiment 1 in which it was 50 ug/ml. The reaction mixtures were incubated for 10 min. In experiments 1 through 4, the concentrations ofthe mouse or human interferon to which the cell cultures were exposed were as indicated in parentheses in column 1 . A portion of cell culture in experiment 2 was (as indicated in parentheses) exposed to interferon for 1.5 h; the interferon treatment of all other cultures lasted for the usual 18 h. In experiment 3, if so indicated, the interferon-treated or control cell cultures were infected with Mengo virus (multiplicity of infection , 10) and S301NT by centrifugation through sucrose gradients (Fig. 7) . Reo mRNA's from all the three size classes were methylated in S30c. The amount of methyl residues incorporated was the highest in the s size class, lower in m, and lowest in 1. The distribution of methyl residues in the three size classes might be accounted for by the fact that the reo mRNAu preparation used was the richest in molecules of the s size class and poorest in molecules of the I size class. Moreover, each reo mRNA molecule (irrespective of its size) is methylated only in its 5' terminal region (26) . The curves in Fig. 7 reveal that in S301NT the methylation of reo mRNAu's from all three size classes was impaired. Further studies will be needed to establish if the methylation of the 10 reo mRNA's is impaired equally or not. The products were also analyzed for determining the sites of methylation. For this purpose portions of reo mRNAu were methylated in S30c and S30INT. Then total RNA was isolated from the reaction mixtures and digested with T2 RNase. This enzyme hydrolyzes phosphodiester bonds between unmethylated nucleosides and produces molecules with 3' phosphate termini (10) . The digestion products were analyzed on a DEAE-cellulose column in the presence of urea (Fig. 8) . This column fractionates molecules according to their net charge (10) . 
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There is no clear-cut difference between S30c and S30INT in the amounts of methylated products carrying between 0 and -3 net charge. These products probably originate from the methylation of endogenous RNA. The amount of methylated products carrying between -4 and -6 net charge is much less in S30INT than in S30C. The majority of these products carried -4 net charge and probably consists of the partially methylated cap structure: m7GpppGp. The product with about -4;5 charge is probably m7GpppGmpCp (7a, 10, 26 ). This type of cap structure is designated as cap 1. It is present in lesser amounts than the partially methylated cap structure. The small amount of products with about -5 net charge might be either m7GpppGmCmpXp (a product designated as cap 2 which might be formed by further methylation of reo mRNAu by cellular enzymes) or might be a partially methylated cap 1 structure with a ring opened m7G moiety. These results indicate that there is a general impairment in cap structure methylation in S30INT.
In a further experiment RNA samples isolated from incubated reaction mixtures containing [3HISAM, reo mRNAu, and either S30c or S30INT were digested to nucleosides by treatment with P1 RNase, nucleotide pyrophosphatase, and bacterial alkaline phosphatase. The resulting digests were supplemented with unlabeled nucleoside markers and analyzed by liquid chromatography on an Aminex-A-5 column (not shown) according to published procedures (7, 7a) . The total nucleoside methylation in S30INT was 74%. (The methylation of endogenous RNA, i.e., not reo mRNAu, was estabnucleosides in S30c was incorporated into 7 methyl-guanosine. The corresponding value in S301NT was 74%. (The methylation of endogenous RNA, i.e., not reo mRNAu, was established in separate control experiments and has been subtracted from the above values.) Over 90% ofthe decrease in total nucleoside methylation in S301NT could be accounted for by a decrease in 7 methyl-guanosine formation.
Methylation of de novo synthesized reo mRNA by the virion-associated enzymes is inhibited by S30INT. The treatment of reo virions with chymotrypsin results in the cleavage and removal of some of the outer coat proteins (19) . The treatment converts the virions into reovirus cores and results in the activation of the virion-associated RNA transcriptase, the capping enzyme, and the RNA methylase(s) (26) . We compared the effect of the addition of esses (Fig. 9) . The rate of core transcription, as measured by [3H]GMP incorporation, was similar in reaction mixtures containing S30c or S30INT (Fig. 9A) or S30pojy(I)PolY(c) (Fig. 9B). [The S30pO1y(j).POjY(c) was prepared from EAT cells that had been treated not with the interferon preparation but with the interferon inducer poly(I) . poly(C) (6) 9E) and so is the extent of methylation of added reo mRNA by both the core-associated methylase(s) (Fig. 9E) and the cellular methylase(s) (Fig. 9F) .
The apparent lack of activity of the cellular methylases in these experiments might be due to the fact that the composition of the reaction mixtures (5) was different from that under which the methylation by cellular RNA methylases was usually assayed (25) . The lack of reo mRNAu methylation by the core methylase may be due either to the inaccessibility of the RNA to the enzyme or the inability of the enzyme to methylate long RNA chains.
Apparent similarity between the inhibition of the core methylase(s) and the cellular methylase in S30INT. The impairment of core methylation in S301NT decreases upon the addition to the reaction mixture of reo mRNAM in increasing concentrations (data not shown). Furthermore, the preincubation of S30NT results in the inactivation ofthe inhibitor of core methylation (Fig. 10) . As indicated earlier, the inhibition of reo mRNAu methylation by cellular enzymes is similarly overcome by either the addition of reo mRNAM or the preincubation of the S301NT.
DISCUSSION
The data presented in this and previous communications (21, 25 The impairment of reo mRNAu methylation in S30INT is not a consequence of: (i) the degradation of reo mRNAu prior to methylation, (ii) the cleavage of reo mRNA after it has been methylated, (iii) the irreversible inactivation of contain core unless so specified. All incubations were at 37°C for the times indicated. [3H]SAM (specific activity, 11.6 Ci/mol) in (C) and (D). All reaction mixtures also contained all four unlabeled ribonucleoside triphosphates, 2 mM each for core methylation, and 2 mMATP, CTP, UTP but only 0.5 mM GTP for core transcription. The other components ofthe reaction mixtures were as specified by Both et al. (5) . The reaction mixtures were incubated at 37°C for the times indicated. pairment of reo mRNA methylation in S301NT is increased by the finding that the methylation of do novo synthesized reo mRNA by the virionassociated methylases (core methylases) is also impaired by S30INT.
The inhibition of the reo mRNA methylating activity of both the cellular and the core methylases can be overcome in the same way: by increasing the concentration of reo mRNAM in VOL. 21, 1977 (a) on September 19, 2017 by guest http://jvi.asm.org/ Downloaded from the reaction mixture or by preincubating the S301NT prior to methylation. Thus it is conceivable that the action of both types of enzymes is impaired by the same inhibitor.
In S301NT the extent of the impairment of core methylases is consistently less than that of the cellular methylases. This might be due to one or more of the following reasons. (i) The access of the inhibitor to the site of RNA synthesis within the cores may be limited. (ii) The ionic conditions used for core methylation might be unfavorable for the action of the inhibitor. (iii) Since the inhibitor of methylation is unstable, it might be partially inactive during the longer incubation periods of the core methylation experiments.
The impairment of core methylation in S301N1 might, in principle, be a consequence of the degradation of reo mRNAu. This is unlikely, however, since the impairment is well manifested after a 15-min incubation, whereas the size distribution of reo mRNA synthesized by reovirus cores in a 15- in S30INT-Since our interferon preparation is not pure, we cannot prove that the agent increasing the activity of the methylation inhibitor in S30IN'I' is interferon and not another component of the preparation. It is in accord with this possibility, however, that the requirements for obtaining the impairment of methylation in the cell extract seem to be identical in our tests to those needed for establishing the antiviral state.
The impairment of methylation in extracts of interferon-treated cells is apparently not restricted to the Ehrlich ascites cell-mouse interferon system. We observed a similar impairment in an extract from HeLa cells which had been treated with a human interferon preparation (S. Shaila and B. Lebleu, manuscript in preparation).
The replication of picornaviruses is also inhibited in interferon-treated cells (9) , though the mRNA's of these viruses were reported to be neither capped nor methylated (8, 17, 23 ; P. Fellner, D. Frisby, J. Goodchild, A. Porter, and N. H. Carey, Abstr. Int. Congr. Virol. Madrid, 3:161). Thus, it is unlikely that an impairment of methylation should be the only mechanism by which virus replication is blocked in interferon-treated cells.
The obvious should be noted: studies with intact, interferon-treated, virus-infected cells will be needed to establish if the agent(s) which impairs reo mRNA methylation in vitro is involved in mediating the antiviral action of interferons.
